Cargando…
Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non–small-cell lung cancer: a case report
With the rapid development of immunotherapy, the efficacy and feasibility of neoadjuvant immunotherapy for early resectable non–small-cell lung cancer (NSCLC) has been demonstrated. However, there are still difficulties and controversies in evaluating the efficacy of neoadjuvant immunotherapy. In ou...
Autores principales: | Liu, Yunpeng, Gao, Zhiru, Zhang, Chengbin, Liu, Xing, Liu, Zihao, Lin, Xingyu, Qian, Benxin, Jin, Fukang, Shao, Guoguang, Yang, Zhiguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670334/ https://www.ncbi.nlm.nih.gov/pubmed/34419961 http://dx.doi.org/10.1097/CAD.0000000000001204 |
Ejemplares similares
-
The Prognosis According to Patterns of Mediastinal Lymph Node Metastasis in Pathologic Stage IIIA/N2 Non-Small Cell Lung Cancer
por: Kim, Do Wan, et al.
Publicado: (2014) -
Echoendoscopy with elastography in mediastinal lymph nodes
por: Colaiacovo, Rogerio, et al.
Publicado: (2019) -
Comparison of mediastinal lymph node status and relapse pattern in clinical stage IIIA non‐small cell lung cancer patients treated with neoadjuvant chemotherapy versus upfront surgery: A single center experience
por: Savic, Milan, et al.
Publicado: (2017) -
Mediastinal lymph node staging for lung cancer
por: Sawabata, Noriyoshi
Publicado: (2019) -
miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2
por: Lin, Xingyu, et al.
Publicado: (2021)